Technical Analysis for ZGNX - Zogenix, Inc.

Grade Last Price % Change Price Change
D 19.24 3.50% 0.65
ZGNX closed up 3.5 percent on Thursday, May 13, 2021, on 1.78 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical ZGNX trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
20 DMA Resistance Bearish 3.50%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.50%
Inside Day Range Contraction 3.50%
20 DMA Resistance Bearish 2.67%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.67%
MACD Bullish Signal Line Cross Bullish 2.67%
Older End-of-Day Signals for ZGNX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 16 hours ago
50 DMA Resistance about 20 hours ago
Up 1 ATR about 20 hours ago
Rose Above 20 DMA about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zogenix, Inc. Description

Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection), a delivery system that offers needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache. The company's lead product candidate, Zohydro, a single-entity extended-release hydrocodone, which has completed Phase III clinical trials for the treatment of moderate to severe chronic pain requiring around-the-clock opioid therapy. It is also developing Relday, an injectable formulation of risperidone, which is in a Phase I clinical trial to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. Zogenix, Inc. markets and sells its Sumavel DosePro to wholesale pharmaceutical distributors and retail pharmacies in the United States. It has a licensing and distribution agreement with Desitin Arzneimittel GmbH to develop and commercialize DosePro in the European Union, Norway, Switzerland, and Turkey. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Pharmaceutical Pain Symptoms Opioid Schizophrenia Chronic Pain Nervous System Disorders Central Nervous System Disorders Morphinans Neurochemistry Migraine Ketones European Union Cell Signaling Headache Retail Pharmacies Treatment Of Migraine Bipolar Disorder Hydrocodone Severe Chronic Pain Treatment Of Central Nervous System Disorders Indoles Moderate To Severe Chronic Pain Pharmaceutical Distributors Relday Triptans

Is ZGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.42
52 Week Low 16.73
Average Volume 588,482
200-Day Moving Average 20.86
50-Day Moving Average 19.37
20-Day Moving Average 18.73
10-Day Moving Average 18.42
Average True Range 0.80
ADX 10.29
+DI 23.62
-DI 22.35
Chandelier Exit (Long, 3 ATRs ) 17.66
Chandelier Exit (Short, 3 ATRs ) 19.12
Upper Bollinger Band 19.78
Lower Bollinger Band 17.67
Percent B (%b) 0.74
BandWidth 11.26
MACD Line -0.23
MACD Signal Line -0.32
MACD Histogram 0.0981
Fundamentals Value
Market Cap 1.07 Billion
Num Shares 55.7 Million
EPS -3.32
Price-to-Earnings (P/E) Ratio -5.80
Price-to-Sales 158.59
Price-to-Book 2.91
PEG Ratio -0.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.14
Resistance 3 (R3) 20.10 19.76 19.99
Resistance 2 (R2) 19.76 19.53 19.78 19.94
Resistance 1 (R1) 19.50 19.39 19.63 19.54 19.89
Pivot Point 19.16 19.16 19.23 19.18 19.16
Support 1 (S1) 18.90 18.93 19.03 18.94 18.59
Support 2 (S2) 18.56 18.79 18.58 18.54
Support 3 (S3) 18.30 18.56 18.49
Support 4 (S4) 18.34